The antipsychotic agent trifluoperazine hydrochloride suppresses triple-negative breast cancer tumor growth and brain metastasis by inducing G0/G1 arrest and apoptosis-Reference-Cited by-同舟云学术

The antipsychotic agent trifluoperazine hydrochloride suppresses triple-negative breast cancer tumor growth and brain metastasis by inducing G0/G1 arrest and apoptosis

Published:2018-09-26 Issue:10 Volume:9 Page:
ISSN:2041-4889
Container-title:Cell Death & Disease
language:en
Short-container-title:Cell Death Dis

Author:

Feng Zhanzhan,Xia Yong,Gao Tiantao,Xu Fuyan,Lei Qian,Peng Cuiting,Yang Yufei,Xue Qiang,Hu Xi,Wang Qianqian,Wang Ranran,Ran Zhiqiang,Zeng Zhilin,Yang Nan,Xie Zixin,Yu Luoting

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Cell Biology,Cellular and Molecular Neuroscience,Immunology

Link

http://www.nature.com/articles/s41419-018-1046-3.pdf

Reference56 articles.

1. Ismail-Khan, R., Minton, S. & Khakpour, N. Triple-negative breast cancer. Drugs 70, 2247–2258 (2015).

2. Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics 2016. CA Cancer J. Clin. 66, 7–30 (2016).

3. Dietze, E. C., Sistrunk, C., Miranda-Carboni, G., O’Regan, R. & Seewaldt, V. L. Triple-negative breast cancer in African-American women: disparities versus biology. Nat. Rev. Cancer 15, 248–254 (2015).

4. Tomao, F. et al. Triple-negative breast cancer: new perspectives for targeted therapies. OncoTargets Ther. 8, 177–193 (2015).

5. Ranjan, A., Gupta, P. & Srivastava, S. K. Penfluridol: an antipsychotic agent suppresses metastatic tumor growth in triple-negative breast cancer by inhibiting integrin signaling axis. Cancer Res. 76, 877–890 (2016).

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trifluoperazine exerts anti-osteosarcoma effect by inducing mitochondria-dependent apoptosis via AKT/TXNIP signaling pathway;Toxicology and Applied Pharmacology;2024-11

2. Risk factors and prognostic factors of brain metastasis of triple-negative breast cancer: A single-center retrospective study;Journal of Cancer Research and Therapeutics;2024-08

3. Drug repurposing: a retrospective revolution in breast cancer medicine;Discover Medicine;2024-07-12

4. Drug repositioning for immunotherapy in breast cancer using single-cell analysis;npj Systems Biology and Applications;2024-04-08

5. Trifluoperazine activates AMPK / mTOR / ULK1 signaling pathway to induce mitophagy in osteosarcoma cells;Chemico-Biological Interactions;2024-04